Allarity Therapeutics, Inc.
ALLR
$1.13
$0.06115.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -105.99% | -44.30% | 14.45% | 24.12% | 25.89% |
| Total Depreciation and Amortization | -75.68% | -43.33% | -34.38% | -38.30% | -38.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 267.52% | 347.87% | -132.62% | -488.47% | -762.12% |
| Change in Net Operating Assets | -98.12% | -145.34% | -69.71% | 105.62% | 1,121.95% |
| Cash from Operations | -36.15% | -17.01% | -25.50% | 22.66% | 24.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 27.62% | -34.63% | -34.63% | 139.00% | 5.00% |
| Total Debt Repaid | 63.77% | 63.74% | 49.49% | -- | -- |
| Issuance of Common Stock | 95.18% | 80.73% | 487.12% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 153.28% | 153.28% | -100.00% | -100.00% | -- |
| Repurchase of Preferred Stock | 47.40% | 47.40% | -202.30% | -332,500.00% | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 234.62% | 188.32% | 590.05% | 7,431.37% | 938.67% |
| Foreign Exchange rate Adjustments | 299.12% | 59.21% | -133.56% | -191.35% | 40.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,139.56% | 769.96% | 359.24% | 100.12% | 89.37% |